Shopping Cart
- Remove All
- Your shopping cart is currently empty
Espindolol is a novel non-selective β blocker with central 5-HT1a and partial β2 receptor agonist effects.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $63 | 6-8 weeks | |
5 mg | $149 | 6-8 weeks | |
10 mg | $197 | 6-8 weeks | |
25 mg | $352 | 6-8 weeks | |
50 mg | $529 | 6-8 weeks | |
100 mg | $797 | 6-8 weeks | |
1 mL x 10 mM (in DMSO) | $164 | 6-8 weeks |
Description | Espindolol is a novel non-selective β blocker with central 5-HT1a and partial β2 receptor agonist effects. |
In vivo | Placebo-treated rats progressively lost body weight (-15.5 ± 7.2 g), lean mass (-1.5 ± 4.2 g), and fat mass (-15.6 ± 2.7 g), while espindolol treatment increased body weight (+8.0 ± 6.1 g, p < 0.05), particularly lean mass (+43.4 ± 3.5 g, p < 0.001), and reduced fat mass further (-38.6 ± 3.4 g, p < 0.001). Anabolic/catabolic signaling was assessed in gastrocnemius muscle. Espindolol decreased proteasome and caspase-3 proteolytic activities by approximately 50 % (all p < 0.05)[1]. |
Alias | MT-102, MT102, MT 102, AGI-001, AGI001, AGI 001 |
Molecular Weight | 248.32 |
Formula | C14H20N2O2 |
Cas No. | 26328-11-0 |
Smiles | CC(C)NC[C@H](O)COc1cccc2[nH]ccc12 |
Relative Density. | 1.152g/cm3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
Solubility Information | DMSO: 55 mg/mL (221.49 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.